From MarketBeat:



Proficio Capital Partners LLC has decreased its shares in iShares Biotechnology ETF by 92.2% during the 3rd quarter, according to the most recent disclosure with the SEC, the recent filing reveals. The financial services provider’s holdings were valued at $220,000. Several other hedge funds have also made changes to their positions in iShares Biotechnology ETF, including Leo Brokerage LLC, Newbridge Financial Services Group Inc., Geneos Wealth Management Inc., WealthCare Investment Partners LLC, and Sharper & Granite LLC Investors own 69.61% of the company’s stock. The stock’s 50-day moving average is $121.38, with a 1-year low of $111.83 and a high of $138.26.

iShares Biotechnology ETF has also announced a quarterly dividend, with a dividend of $0.124 per share to be paid on December 27th. Finally, the iShares Nasdaq Biotechnology ETF is an exchange-traded fund that seeks investment results corresponding to the performance of the NASDAQ Biotechnology Index. Other hedge funds and their holdings in iShares Biotechnology ETF can be found at HoldingsChannel.com. Investors should note that analysts have given a “hold” rating to iShares Biotechnology ETF.



Read more: Proficio Capital Partners LLC Cuts Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)